Cytokinetics Inc. buy Morgan Stanley
Start price
04.08.23
/
50%
€30.20
Target price
04.08.24
€54.39
Performance (%)
85.43%
Price
15.05.24
€56.00
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley for Cytokinetics Inc. has seen massive gains of 85.43%. This prediction currently runs until 04.08.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -7.438% | -7.438% |
| iShares Core DAX® | 1.851% | 5.158% |
| iShares Nasdaq 100 | 1.573% | 2.589% |
| iShares Nikkei 225® | -0.412% | -2.857% |
| iShares S&P 500 | 1.128% | 2.485% |
Comments by Morgan_Stanley for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $60.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat